A review and meta-analysis of stem cell therapies in stroke patients: effectiveness and safety evaluation.

Hovhannisyan, L; Khachatryan, S; Khamperyan, A; Matinyan, S (2024). A review and meta-analysis of stem cell therapies in stroke patients: effectiveness and safety evaluation. Neurological sciences, 45(1), pp. 65-74. Springer 10.1007/s10072-023-07032-z

[img] Text
s10072-023-07032-z.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

PURPOSE

Stem cells have been extensively used during the last decade to improve clinical outcomes after stroke. The dramatic increase in trials in this field has led us to perform a systematic review and meta-analysis to understand the safety, effectiveness, and relative limitations of this type of intervention.

METHOD

This review summarizes the current evidence pooled from PubMed (Medline), EMBASE, EBSCOhost, http://clinicaltrials.gov , Scopus (Elsevier), Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science (Science Citation Index Expanded) databases for the use of stem cell therapies in stroke patients without combinations with other treatment modalities. The National Institutes of Health Stroke, modified Rankin Scales, and Barthel Index scores after external stem cell administration have been evaluated on the 3rd, 6th, and 12th months after treatment. The random effect analysis was performed using the Review Manager 5.4.1. The characteristics of stem cell sources and their adverse effects have been discussed as well.

FINDINGS

Although reasonably safe, the effectiveness evidence fluctuated to a large extent due to the heterogeneity of the clinical trials and the absence of a systematic approach. The stem cell sources and the administration window were not strongly associated with clinical outcomes.

CONCLUSION

Further studies should be conducted to understand the deep discrepancy between preclinical and clinical trials and to execute phase 3 clinical trials with robust control of study characteristics and outcomes.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Hovhannisyan, Lusine

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1590-1874

Publisher:

Springer

Language:

English

Submitter:

Pubmed Import

Date Deposited:

22 Sep 2023 11:42

Last Modified:

03 Jan 2024 00:13

Publisher DOI:

10.1007/s10072-023-07032-z

PubMed ID:

37733251

Uncontrolled Keywords:

BI NIHSS Stem cell Stroke mRS

BORIS DOI:

10.48350/186500

URI:

https://boris.unibe.ch/id/eprint/186500

Actions (login required)

Edit item Edit item
Provide Feedback